Getting the word out – Making Anal Cancer History
|
|
London Calling Global conference on anal cancer and other anal HPV-associated conditions In-Person Event The 2025 in-person event will showcase invited presentations, abstracts, small group sessions and a lively scientific interchange on anal HPV infection, anal squamous intraepithelial lesions and anal cancer. Who attends the IANS Scientific Meeting? Scientists, researchers, physicians and advanced practice clinicians who are involved in anal HPV-associated and related diseases. This meeting highlights cutting edge research and clinical care for populations most impacted by HPV including MSM, men and women with HIV disease and women with HPV related disease. Attendees will include professionals from multiple fields, including molecular biology, epidemiology, pathology and direct clinical care providers such as family practice, internal medicine and infectious disease, gastroenterology, general surgery, colorectal surgery and gynecology. |
Educational Learning objectives
- Understanding who is at risk, prioritizing for screening and the optimal approaches to screening once the decision to screen is made
- Increased knowledge and understanding of the pathogenesis of anal HSIL and cancer
- Evaluation of treatments and awareness of potential new treatments
- Discussion of HRA practices, challenges and successes in different international communities
- To determine the utility of preventive vaccines in older populations, in prevention of recurrent HSIL